Category Archives: Indian Patent Law

“Indian CSO letter to the DPIIT on the proposed amendment to the Patent Rules”

Posted on May 20, 2019 by donttradeourlivesaway

20th May, 2019   New Delhi 16 May 2019 To Shri Ramesh Abhishek Secretary, Department for Promotion of Industry and Internal Trade, Ministry of Commerce & Industry, Room No.157 Udyog Bhawan, New Delhi Telephone : 2306 1815, 2306 1667, 23061598(F) … Continue reading →

Posted in Fast track patent examination, Indian Patent Law, Patent examination system, Sec 3 (d) | Leave a comment

People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India

Posted on July 10, 2018 by donttradeourlivesaway

New Delhi, 10 July 2018: Delhi Network of Positive People (DNP+) has filed today two patent oppositions before the Indian patent office, challenging additional patent claims by US pharmaceutical corporation-Gilead Sciences for the hepatitis C medicines sofosbuvir and velpatasvir. These … Continue reading →

Posted in Drug prices, Hepatitis C, Indian Patent Law, Patent, Patent Opposition, Sec 3 (d) | Tagged , | Leave a comment

Five years after the Indian Supreme Court’s novartis verdict

Posted on May 31, 2018 by donttradeourlivesaway

Source: Intellectual Property Watch | May 21, 2018 On 1 April 2013, in a packed room inside India’s Supreme Court, a magnificent building in Indo-British architectural style, two judges delivered a verdict that impacted the national and global conversation about … Continue reading →

Posted in Novartis Case, Sec 3 (d) | Leave a comment

Weed out evergreen patents

Posted on May 30, 2018 by donttradeourlivesaway

Source: Live Law | May 27, 2018 A recently published report “Pharmaceutical Patent Grants in India: How our safeguards against evergreening have failed and why the system must be reformed“, by Dr. Feroz Ali, Dr. Sudarsan Rajagopal, Dr. Venkata S. … Continue reading →

Posted in Evergreening, Patents, Sec 3 (d) | Leave a comment

Why the US and pharmaceutical giants want a provision in India’s patent law revoked

Posted on May 7, 2018 by donttradeourlivesaway

Source: Scroll.in | May 02, 2018 India’s patent laws are under attack again. This time, too, the target is a provision not commonly found in patent laws elsewhere. This rule requires patent holders to disclose whether they are working their … Continue reading →

Posted in Generics, Indian Patent Law, IPR, Patents | Leave a comment

Report on Pharmaceutical Patents in India – How our safeguards against evergreening have failed, and why the system must be reformed

Posted on April 27, 2018 by donttradeourlivesaway

  The recent report on “Pharmaceutical Patent Grants in India How our safeguards against evergreening have failed, and why the system must be reformed” shows immense irregularities in grant of patents in the country. Over the past decades India’s patent system has … Continue reading →

Posted in Evergreening, Fix the patent law, India, Indian Patent Law, Indian Patent Office | Leave a comment

Rampant evergreening in Indian pharma industry

Posted on April 27, 2018 by donttradeourlivesaway

Source: live mint | April 27, 2018 Pharmaceutical companies commonly used legal argument, as opposed to demonstrating proof of therapeutic efficacy, to overcome anti-evergreening objections India has been at the forefront of developing an alternative model of patent law which … Continue reading →

Posted in Indian Patent Law, Indian Patent Office, Sec 3 (d), Uncategorized | Leave a comment

72% of drug patent grants in India for marginal improvements, says study

Posted on April 27, 2018 by donttradeourlivesaway

Source: Business Today | April 25, 2018 Majority of pharmaceutical drug patents granted by India might have skipped elaborate scrutiny, an analysis of patent grants by a team of researchers and patent lawyers reveals. The report which studied the prosecution history of … Continue reading →

Posted in Fix the patent law, India, Indian Patent Law, Indian Patent Office, Uncategorized | Leave a comment

72% of drug patent grants in India for marginal improvements, says study

Posted on April 26, 2018 by donttradeourlivesaway

Source: Business Today | April 25, 2018 Majority of pharmaceutical drug patents granted by India might have skipped elaborate scrutiny, an analysis of patent grants by a team of researchers and patent lawyers reveals.   The report which studied the prosecution … Continue reading →

Posted in Indian Patent Office, Patent, Patent Enforcement, Patents, Sec 3 (d) | Leave a comment

U.S. wants patent form recall

Posted on April 16, 2018 by donttradeourlivesaway

Source: The Hindu | April 15, 2018 Submission on interpretation of a domestic patent law raises eyebrows The United States Patent and Trademark Office (USPTO) has demanded the elimination of ‘Form 27’— a statutory requirement unique to India’s patent law … Continue reading →

Posted in Indian Patent Law, Indian Patent Office, IP Rights, IPR, Patent Enforcement, Patent infringement, US pressure on India | Leave a comment